Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nasdaq First North is a leading growth market in Europe, specifically tailored for small and medium-sized enterprises (SMEs) in the Nordic and Baltic regions. As a division of Nasdaq Nordic, it operates as a multilateral trading facility (MTF) that offers a more flexible regulatory environment than the main market, facilitating easier access to public capital for emerging companies. It is particularly significant for the life sciences sector, serving as a primary listing venue for numerous early-stage biotech, medtech, and healthcare companies. The exchange provides a pathway for these firms to gain institutional investor exposure and eventually transition to a regulated main market. It plays a critical role in the European innovation ecosystem by providing liquidity and visibility to growth-oriented businesses.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nasdaq First North.